LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 39 of 497
Next
>>
>
951 to 975 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	PLX-4720	0.37	uM	LJP5	3	K04	72	hr	1097	3440	3769	0.9126	0.8767
BT-20	QL-X-138	0.37	uM	LJP6	1	F22	72	hr	1097	2518	3769	0.6680	0.5317
BT-20	QL-X-138	0.37	uM	LJP6	2	F22	72	hr	1097	2513	3769	0.6667	0.5298
BT-20	QL-X-138	0.37	uM	LJP6	3	F22	72	hr	1097	2000	3769	0.5306	0.3378
BT-20	QL-XII-47	0.37	uM	LJP6	1	O22	72	hr	1097	1163	3769	0.3085	0.0246
BT-20	QL-XII-47	0.37	uM	LJP6	2	O22	72	hr	1097	1157	3769	0.3069	0.0224
BT-20	QL-XII-47	0.37	uM	LJP6	3	O22	72	hr	1097	1272	3769	0.3374	0.0654
BT-20	Radicicol	0.37	uM	LJP5	1	K10	72	hr	1097	1646	3769	0.4367	0.2054
BT-20	Radicicol	0.37	uM	LJP5	2	K10	72	hr	1097	1417	3769	0.3759	0.1197
BT-20	Radicicol	0.37	uM	LJP5	3	K10	72	hr	1097	1279	3769	0.3393	0.0680
BT-20	Radicicol	0.37	uM	LJP6	1	K10	72	hr	1097	1347	3769	0.3573	0.0935
BT-20	Radicicol	0.37	uM	LJP6	2	K10	72	hr	1097	1265	3769	0.3356	0.0628
BT-20	Radicicol	0.37	uM	LJP6	3	K10	72	hr	1097	1254	3769	0.3327	0.0587
BT-20	Seliciclib	0.37	uM	LJP5	1	J04	72	hr	1097	3345	3769	0.8874	0.8411
BT-20	Seliciclib	0.37	uM	LJP5	2	J04	72	hr	1097	3488	3769	0.9253	0.8946
BT-20	Seliciclib	0.37	uM	LJP5	3	J04	72	hr	1097	3488	3769	0.9253	0.8946
BT-20	Ruxolitinib	0.37	uM	LJP5	1	O16	72	hr	1097	3740	3769	0.9922	0.9890
BT-20	Ruxolitinib	0.37	uM	LJP5	2	O16	72	hr	1097	3670	3769	0.9736	0.9628
BT-20	Ruxolitinib	0.37	uM	LJP5	3	O16	72	hr	1097	3557	3769	0.9436	0.9205
BT-20	XL147	0.37	uM	LJP5	1	G10	72	hr	1097	4150	3769	1.1009	1.1424
BT-20	XL147	0.37	uM	LJP5	2	G10	72	hr	1097	4259	3769	1.1298	1.1832
BT-20	XL147	0.37	uM	LJP5	3	G10	72	hr	1097	4050	3769	1.0744	1.1050
BT-20	Saracatinib	0.37	uM	LJP6	1	D10	72	hr	1097	3290	3769	0.8728	0.8206
BT-20	Saracatinib	0.37	uM	LJP6	2	D10	72	hr	1097	3131	3769	0.8306	0.7611
BT-20	Saracatinib	0.37	uM	LJP6	3	D10	72	hr	1097	3102	3769	0.8229	0.7502

|<
<<
Previous
Page 39 of 497
Next
>>
>
951 to 975 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)